Arca
Skip to content
Tools
Tools

Hip fracture

Drug research and approvals for hip fracture: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 118 studies of hip fracture are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 118
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting now

Newest posted first, of 118 recruiting on ClinicalTrials.gov ↗

How its trials ended

731 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 125 whose ending is known, 29% met their primary endpoint, 10% missed it and 62% stopped early.

  • Completed, result not reported30942%
  • Ongoing15421%
  • Status unknown14320%
  • Stopped: other or unclear416%
  • Met its primary endpoint365%
  • Stopped: enrollment or feasibility233%
  • Missed its primary endpoint122%
  • Stopped: sponsor or business decision61%
  • Stopped: lack of efficacy51%
  • Stopped: funding2<1%

Trials authorized in Canada

Newest first; search them all in Canada trials
Oct 16, 2023Hip fracture oral thromboprophylaxis: a pilot randomized controlled trial (hip pro pilot)Rivaroxaban / Acetylsalicylic acidGovernors of The University of CalgaryOngoing
Mar 23, 2016Topical tranexamic acid (TXA) in hip fractures, a double-blind randomized controlled trialTranexamic acidSault Area HospitalOngoing
Feb 3, 2015Direct-application of tranexamic acid for hip fracture: a randomized controlled trialTranexamic acidUniversity Health NetworkPending

Medicines authorised in the EU

Newest first
Apr 15, 2005AclastaZoledronic acidSandoz Pharmaceuticals d.d.EMA ↗
Mar 20, 2002ArixtraFondaparinux sodiumViatris Healthcare LimitedEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.